Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch Health Companies Inc.BHC · Entity 4363 | Director | September 30, 2026 | October 03, 2026 |
| Damora Therapeutics, Inc.GLTO · Entity 4602 | Director | June 18, 2025 | June 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch Health Companies Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 316,158 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 1,179 · Balance 316,158 F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.
Damora Therapeutics, Inc.
Report date June 18, 2025 · Filed June 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.22 · Expires 2035-06-18 | Direct | 720 |
Reported balance
After 2025-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-18 · Grant · Acquired 720 · Balance 720 F1: Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 18, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 18, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,179 | $5.83 | $6,873.57 |
DisclosureSEC source: 0000885590-26-000111 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,158 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:13 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,394 | $4.93 | $6,872.42 |
DisclosureSEC source: 0000885590-26-000095 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,979 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| May 22, 2026 Filed May 26, 2026 23:05 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 45,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000083 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 313,585 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 22:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,273 | $5.40 | $6,874.20 |
DisclosureSEC source: 0000885590-26-000043 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,714 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 21:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 989 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000001 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,441 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:10 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,065 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-25-000037 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,452 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:33 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018670 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,387 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 11:00 UTC | Damora Therapeutics, Inc. GLTO · Entity 4602 | GrantStock Option (right to buy) · Derivative | 720 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0000950170-25-088163 · ownership.xml · derivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires 2035-06-18 F1 · derivative.exercise_date: Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 18, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:20 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 54,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015018 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,355 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:36 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,062 | $6.47 | $6,871.14 |
DisclosureSEC source: 0001127602-25-010797 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,008 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 12:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 852 | $8.06 | $6,867.12 |
DisclosureSEC source: 0001127602-25-000003 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,946 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:15 UTC | Damora Therapeutics, Inc. GLTO · Entity 4602 | GrantStock Option (right to buy) · Derivative | 480 | $0.00 Strike: $6.92 | $0.00 |
DisclosureSEC source: 0000950170-24-114680 · ownership.xml · derivative · entry 2 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480 Underlying: Common Stock · 480 shares Expires 2034-10-11 F2 · derivative.exercise_date: Represents a pro-rated annual option grant to a non-employee director upon appointment to the Board of Directors of the Company. The shares subject to such option vest in twelve equal monthly installments, commencing on the Award Date, subject in each case to the grantee's continued service through the applicable vesting date. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:15 UTC | Damora Therapeutics, Inc. GLTO · Entity 4602 | GrantStock Option (right to buy) · Derivative | 720 | $0.00 Strike: $6.92 | $0.00 |
DisclosureSEC source: 0000950170-24-114680 · ownership.xml · derivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires 2034-10-11 F1 · derivative.exercise_date: The shares subject to such option vest in 36 equal monthly installments over three years from the Award Date, subject in each case to the grantee's continued service through the applicable vesting date. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:17 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 842 | $8.16 | $6,870.72 |
DisclosureSEC source: 0001127602-24-024691 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,094 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 986 | $6.97 | $6,872.42 |
DisclosureSEC source: 0001127602-24-019574 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,252 F1 · shares: Reflects Restricted Share Units issued?in?lieu?of?cash?compensation?in?connection with the Reporting Person's service on the Issuer's Board?of?Directors for the quarter ending June 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| May 17, 2024 Filed May 20, 2024 22:04 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 35,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016041 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,266 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 29, 2024 Filed Apr 1, 2024 20:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 647 | $10.61 | $6,864.67 |
DisclosureSEC source: 0001127602-24-011591 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,906 F1 · price: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:15 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 857 | $8.02 | $6,873.14 |
DisclosureSEC source: 0001127602-24-000122 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,259 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 836 | $8.22 | $6,871.92 |
DisclosureSEC source: 0001127602-23-025007 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,402 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:09 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 859 | $8.00 | $6,872.00 |
DisclosureSEC source: 0001127602-23-020005 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,566 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 19, 2023 Filed May 19, 2023 20:26 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 29,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016302 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,707 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 22:07 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 848 | $8.10 | $6,868.80 |
DisclosureSEC source: 0001127602-23-012413 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,502 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 21:59 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,094 | $6.28 | $6,870.32 |
DisclosureSEC source: 0001127602-23-000165 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,654 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 997 | $6.89 | $6,869.33 |
DisclosureSEC source: 0001127602-22-023269 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,560 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:02 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 822 | $8.36 | $6,871.92 |
DisclosureSEC source: 0001127602-22-018806 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,563 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018205 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,741 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:13 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 300 | $22.85 | $6,855.00 |
DisclosureSEC source: 0001127602-22-011305 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,354 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 249 | $27.61 | $6,874.89 |
DisclosureSEC source: 0001127602-22-000102 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,054 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:48 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 246 | $27.85 | $6,851.10 |
DisclosureSEC source: 0001127602-21-026458 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,805 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 234 | $29.32 | $6,860.88 |
DisclosureSEC source: 0001127602-21-021238 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,559 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:34 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 11,037 | $31.79 | $350,811.05 |
DisclosureSEC source: 0001127602-21-018330 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,325 Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014921 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,362 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:20 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 216 | $31.74 | $6,855.84 |
DisclosureSEC source: 0001127602-21-012770 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,717 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 23:59 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 330 | $20.80 | $6,864.00 |
DisclosureSEC source: 0001127602-21-000250 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,501 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:03 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 442 | $15.54 | $6,868.68 |
DisclosureSEC source: 0001127602-20-026312 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,171 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:39 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 375 | $18.29 | $6,858.75 |
DisclosureSEC source: 0001127602-20-020938 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,729 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 01, 2020 Filed May 1, 2020 20:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 11,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015050 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,354 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:32 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 443 | $15.50 | $6,866.50 |
DisclosureSEC source: 0001127602-20-012714 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,317 Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,065 | $29.92 | $31,864.80 |
DisclosureSEC source: 0001127602-20-000201 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,874 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,458 | $21.85 | $31,857.30 |
DisclosureSEC source: 0001127602-19-029786 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,809 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:22 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,263 | $25.22 | $31,852.86 |
DisclosureSEC source: 0001127602-19-023546 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,351 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:21 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017275 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,088 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| March 29, 2019 Filed Apr 3, 2019 21:08 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,290 | $24.70 | $31,863.00 |
DisclosureSEC source: 0001127602-19-014693 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,455 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:34 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,716 | $18.47 | $31,694.52 |
DisclosureSEC source: 0001127602-19-000723 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,165 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 20:38 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,217 | $25.67 | $31,240.39 |
DisclosureSEC source: 0001127602-18-029071 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,449 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:31 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,344 | $23.24 | $31,234.56 |
DisclosureSEC source: 0001127602-18-022645 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,232 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
| May 03, 2018 Filed May 4, 2018 22:02 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 14,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016414 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,292 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant. Read SEC document |
| May 03, 2018 Filed May 8, 2018 20:43 UTC Amendment | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 13,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016657 · form4a.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,888 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on May 3, 2018 as reported on the Form 4 filed on May 4, 2018. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 21:03 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,962 | $15.92 | $31,235.04 |
DisclosureSEC source: 0001127602-18-013772 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,007 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 15:13 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,503 | $20.78 | $31,232.34 |
DisclosureSEC source: 0001127602-18-000334 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,045 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.